These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 15656390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinico-statistical study on the activity of a phlebo-active drug Fleboplex in obstetrical and gynecologic pathology].
    Ricci MG.
    Minerva Ginecol; 1974 Nov; 26(11):641-6. PubMed ID: 4444806
    [No Abstract] [Full Text] [Related]

  • 3. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
    Iablokov EG, Bogachev VIu, Domoradskaia AI.
    Ter Arkh; 1996 Nov; 68(10):80-1. PubMed ID: 9026954
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of the therapeutic effect of a phlebotropic drug with a new noninvasive method: rheography by reflected light].
    Tumino G, Berni A, Tromba L, Marignetti L.
    Clin Ter; 1987 Aug 15; 122(3):189-94. PubMed ID: 2973911
    [No Abstract] [Full Text] [Related]

  • 5. Techniques used to evaluate the cutaneous microcirculation: application of photoplethysmography to the assessment of a phlebotropic agent in the treatment of leg ulcers.
    Guillot B.
    Angiology; 1994 Jun 15; 45(6 Pt 2):542-8. PubMed ID: 8203785
    [Abstract] [Full Text] [Related]

  • 6. At the crossroads of venous insufficiency and hemorrhoidal disease: Daflon 500 mg--repercussions of venous insufficiency on everyday life.
    Launois R.
    Angiology; 1994 Jun 15; 45(6 Pt 2):495-504. PubMed ID: 8203779
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical experiences with a vasoprotective drug in the treatment of venous problems of the lower limbs].
    De Caprio M, Vinci L, Giumetti D, Colitta G.
    Clin Ter; 1982 Jun 15; 101(5):497-508. PubMed ID: 6897029
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. At the Crossroads of Venous Insufficiency and Hemorrhoidal Disease: Daflon 500 mg. Proceedings of a symposium. Vienna, Austria, January 31, 1992.
    Angiology; 1994 Jun 15; 45(6 Pt 2):493-584. PubMed ID: 7911285
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of the efficacy of a phlebotropic drug by the Doppler method].
    Severin E, Mladovan G.
    Minerva Cardioangiol; 1988 Jun 15; 36(7-8):375-6. PubMed ID: 3062488
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C.
    Angiology; 1994 Jun 15; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.